Clinical Trial Update: Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chidamide in combination with exemestane in advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chidamide (chidamide)
• Exemestane (Exemestane)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED